ASX - By Stock
|
HUM |
Re:
Fintech provider BidFin acquired by humm
|
|
grimloq
|
2 |
608 |
0 |
30/04/24 |
30/04/24 |
ASX - By Stock
|
2
|
608
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
266
|
114K
|
0
|
|
ASX - By Stock
|
ATG |
Re:
Ann: 1HFY24 Investor Presentation
|
|
grimloq
|
14 |
7.0K |
0 |
28/03/24 |
28/03/24 |
ASX - By Stock
|
14
|
7.0K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
3 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
266
|
114K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: PYC Equity Raising to Raise up to $74.6 Million
|
|
grimloq
|
19 |
9.0K |
10 |
19/03/24 |
19/03/24 |
ASX - By Stock
|
19
|
9.0K
|
10
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
266
|
114K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
266
|
114K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Half Yearly Report and Accounts
|
|
grimloq
|
8 |
3.3K |
3 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
8
|
3.3K
|
3
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Half Year Accounts
|
|
grimloq
|
6 |
2.1K |
0 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
6
|
2.1K
|
0
|
|
ASX - By Stock
|
HUM |
Re:
Ann: 1H24 Results Announcement
|
|
grimloq
|
71 |
26K |
3 |
20/02/24 |
20/02/24 |
ASX - By Stock
|
71
|
26K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q1 2024 Investor Webinar Presentation
|
|
grimloq
|
10 |
4.4K |
1 |
03/02/24 |
03/02/24 |
ASX - By Stock
|
10
|
4.4K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
10 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
266
|
114K
|
10
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Investment Portfolio Report at 31 December 2023
|
|
grimloq
|
4 |
1.8K |
3 |
25/01/24 |
25/01/24 |
ASX - By Stock
|
4
|
1.8K
|
3
|
|
ASX - By Stock
|
HUM |
Re:
Ann: Update - Notification of buy-back - HUM
|
|
grimloq
|
98 |
29K |
8 |
23/01/24 |
23/01/24 |
ASX - By Stock
|
98
|
29K
|
8
|
|
ASX - By Stock
|
PYC Biotech |
Re:
PYC Chart and Technical Analysis
|
|
grimloq
|
113 |
45K |
4 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
113
|
45K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
Ann: AI Driven Drug Discovery Collaboration with Google Cloud
|
|
grimloq
|
41 |
17K |
7 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
41
|
17K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: AI Driven Drug Discovery Collaboration with Google Cloud
|
|
grimloq
|
41 |
17K |
8 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
41
|
17K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
1 |
14/12/23 |
14/12/23 |
ASX - By Stock
|
266
|
114K
|
1
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Secondary Market Transaction in Fund 4
|
|
grimloq
|
6 |
3.3K |
2 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
6
|
3.3K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
along for the ride
|
|
grimloq
|
22 |
11K |
8 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
22
|
11K
|
8
|
|
ASX - By Stock
|
PYC |
Re:
along for the ride
|
|
grimloq
|
22 |
11K |
4 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
22
|
11K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
along for the ride
|
|
grimloq
|
22 |
11K |
0 |
03/12/23 |
03/12/23 |
ASX - By Stock
|
22
|
11K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
along for the ride
|
|
grimloq
|
22 |
11K |
5 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
22
|
11K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
7 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
266
|
114K
|
7
|
|
ASX - By Stock
|
PYC |
Re:
Ann: 2023 AGM Chairman's Address and CEO Presentation
|
|
grimloq
|
40 |
16K |
0 |
24/11/23 |
24/11/23 |
ASX - By Stock
|
40
|
16K
|
0
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
266
|
114K
|
4
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
1 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
266
|
114K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
grimloq
|
266 |
114K |
2 |
21/11/23 |
21/11/23 |
ASX - By Stock
|
266
|
114K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
grimloq
|
56 |
18K |
3 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
56
|
18K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
grimloq
|
56 |
18K |
2 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
56
|
18K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Polycystic Kidney Disease Program Presentation
|
|
grimloq
|
10 |
4.9K |
9 |
17/11/23 |
17/11/23 |
ASX - By Stock
|
10
|
4.9K
|
9
|
|
ASX - By Stock
|
HUM |
Re:
Ann: AGM CEO address
|
|
grimloq
|
10 |
2.8K |
1 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
10
|
2.8K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
grimloq
|
56 |
18K |
2 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
56
|
18K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
grimloq
|
56 |
18K |
9 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
56
|
18K
|
9
|
|
ASX - By Stock
|
PYC |
Re:
Ann: New Drug For Major Kidney Disease Effective In Human Models
|
|
grimloq
|
56 |
18K |
3 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
56
|
18K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
News: PYC PYC Therapeutics Holds Pre-IND Meeting With US FDA
|
|
grimloq
|
17 |
5.8K |
3 |
10/11/23 |
10/11/23 |
ASX - By Stock
|
17
|
5.8K
|
3
|
|
ASX - By Stock
|
PYC |
Re:
Ann: RP11 Clinical Trial Dosing Completed In Patient Cohort 2
|
|
grimloq
|
2 |
1.5K |
17 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
2
|
1.5K
|
17
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Wilsons Drug & Device Conference Presentation
|
|
grimloq
|
2 |
1.6K |
2 |
30/10/23 |
30/10/23 |
ASX - By Stock
|
2
|
1.6K
|
2
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Change in substantial holding
|
|
grimloq
|
6 |
2.6K |
1 |
12/10/23 |
12/10/23 |
ASX - By Stock
|
6
|
2.6K
|
1
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call Presentation
|
|
grimloq
|
16 |
5.8K |
0 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
16
|
5.8K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
grimloq
|
2 |
1.2K |
2 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
2
|
1.2K
|
2
|
|
ASX - By Stock
|
PYC |
Re:
Price
|
|
grimloq
|
16 |
5.2K |
5 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
16
|
5.2K
|
5
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 Investor Call 27 September 2023
|
|
grimloq
|
20 |
5.8K |
1 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
20
|
5.8K
|
1
|
|
ASX - By Stock
|
HUM |
Re:
Ann: Change of Director's Interest Notice - A Abercrombie
|
|
grimloq
|
20 |
7.7K |
2 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
20
|
7.7K
|
2
|
|
ASX - By Stock
|
OBL |
Re:
Ann: FY23 Full year results investor presentation
|
|
grimloq
|
29 |
16K |
0 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
29
|
16K
|
0
|
|
ASX - By Stock
|
OBL |
Re:
Ann: FY23 Full year results investor presentation
|
|
grimloq
|
29 |
16K |
3 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
29
|
16K
|
3
|
|
ASX - By Stock
|
HUM |
Re:
Humm Valuation - What is Sensible
|
|
grimloq
|
134 |
58K |
4 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
134
|
58K
|
4
|
|
ASX - By Stock
|
PYC |
IRA act will help orphan drug developers
|
|
grimloq
|
3 |
1.3K |
10 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
3
|
1.3K
|
10
|
|
ASX - By Stock
|
OBL |
Re:
Ann: FY23 Full year results investor presentation
|
|
grimloq
|
29 |
16K |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
29
|
16K
|
3
|
|
ASX - By Stock
|
HUM |
Re:
Humm Valuation - What is Sensible
|
|
grimloq
|
134 |
58K |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
134
|
58K
|
3
|
|